open access

Vol 17, No 2 (2010)
Original articles
Submitted: 2013-01-14
Published online: 2010-03-29
Get Citation

Arrhythmogenic right ventricular cardiomyopathy/dysplasia in Iraq

Amar Al-Hamdi, Tahseen Ali Al-Kinani, Adnan Taan Al-Khafaji, Mouayed Basheer Hamed, Mohammed Hashim Al-Mayahi, Nazar Hassan Al-Sudani
Cardiol J 2010;17(2):172-178.

open access

Vol 17, No 2 (2010)
Original articles
Submitted: 2013-01-14
Published online: 2010-03-29

Abstract

Background: Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a disorder that involves replacement of the right ventricular myocardium with fibro-fatty tissue. Ventricular tachycardia is a main presenting feature. There are no known reports of this disease from the Arab countries in the Middle East. This is the first report of 34 patients from Iraq.
Methods: Thirty four patients with ARVC/D diagnosed from January 2003 to May 2007 according to the International Task Force criteria were included in this study.
Results: All patients presented with ventricular tachycardia of left bundle branch block morphology. The following findings were seen on the 12-lead electrocardiography during sinus rhythm: T wave inversion V1-V3 or beyond in 80%, epsilon wave in 28%, and parietal block in 48%. Right ventricular enlargement by echocardiography was seen in 69%. Twenty two per cent had a family history of sudden cardiac death. All patients were treated with implanted cardioverter-defibrillators.
Conclusions: ARVC/D is a disease seen in Iraq. It requires a high diagnostic suspicion with verification using the international task force criteria.
(Cardiol J 2010; 17, 2: 172-178)

Abstract

Background: Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a disorder that involves replacement of the right ventricular myocardium with fibro-fatty tissue. Ventricular tachycardia is a main presenting feature. There are no known reports of this disease from the Arab countries in the Middle East. This is the first report of 34 patients from Iraq.
Methods: Thirty four patients with ARVC/D diagnosed from January 2003 to May 2007 according to the International Task Force criteria were included in this study.
Results: All patients presented with ventricular tachycardia of left bundle branch block morphology. The following findings were seen on the 12-lead electrocardiography during sinus rhythm: T wave inversion V1-V3 or beyond in 80%, epsilon wave in 28%, and parietal block in 48%. Right ventricular enlargement by echocardiography was seen in 69%. Twenty two per cent had a family history of sudden cardiac death. All patients were treated with implanted cardioverter-defibrillators.
Conclusions: ARVC/D is a disease seen in Iraq. It requires a high diagnostic suspicion with verification using the international task force criteria.
(Cardiol J 2010; 17, 2: 172-178)
Get Citation

Keywords

arrhythmogenic right ventricular cardiomyopathy/dysplasia; Iraq

About this article
Title

Arrhythmogenic right ventricular cardiomyopathy/dysplasia in Iraq

Journal

Cardiology Journal

Issue

Vol 17, No 2 (2010)

Pages

172-178

Published online

2010-03-29

Page views

669

Article views/downloads

1567

Bibliographic record

Cardiol J 2010;17(2):172-178.

Keywords

arrhythmogenic right ventricular cardiomyopathy/dysplasia
Iraq

Authors

Amar Al-Hamdi
Tahseen Ali Al-Kinani
Adnan Taan Al-Khafaji
Mouayed Basheer Hamed
Mohammed Hashim Al-Mayahi
Nazar Hassan Al-Sudani

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl